About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Nextgen
Gemabank
Biotechnology Developments
Genetico
Betuvax
Histograft
Genotarget
Reprobank
Vitacel
26.03.2025
News
Artgen Biotech shares will be available for trading on weekends
26.03.2025
Press releases
Genetico invests into the developer of gene therapy drugs for eye therapy
17.03.2025
Press releases
Gemabank’s income increased by 23% in 2024
12.03.2025
Press releases
MoH approved trials of a new diabetic foot drug
28.02.2025
Press releases
Genetico received a patent for Onconetix panel for genetic testing of tumors
21.02.2025
Press releases
Nextgen started trials of a drug against hair loss
19.02.2025
Press releases
The CB cancelled Artgen Biotech’s additional issue
1
2
3
4
…
19
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
